SCHEMBL9681349

SCHEMBL9681349

CCc1cc(NCc2cc3ccccc3nc2OC)c(=O)[nH]c1CO

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 8/20 0.40
KDM4E B2RXH2 6/20 0.40
ALDH1A1 P00352 4/20 0.40
GAA P10253 4/20 0.40
HIF1A Q16665 1/20 0.40
APAF1 O14727 2/20 0.39
RECQL P46063 1/20 0.39
BTK Q06187 1/20 0.39
IDH1 O75874 2/20 0.37
ALOX12 P18054 1/20 0.37
PDE10A Q9Y233 2/20 0.37
SMN1; SMN2 Q16637 3/20 0.36
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
HDAC3 O15379 4/20 0.35
HDAC1 Q13547 4/20 0.35
HDAC2 Q92769 2/20 0.34
HDAC8 Q9BY41 2/20 0.34
NR1I2 O75469 1/20 0.34
CYP2C9 P11712 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9846230 0.86 BTK (0.41) MAPTKDM4EALDH1A1GAAHIF1A
SCHEMBL9681915 0.85 PDE10A (0.40) MAPTKDM4EALDH1A1GAAHIF1A
SCHEMBL9681299 0.83 MAPT (0.35) MAPTKDM4EALDH1A1GAAHIF1A
SCHEMBL9681421 0.82 MAPT (0.37) MAPTKDM4EALDH1A1GAAHIF1A
SCHEMBL9681437 0.78 NPSR1 (0.34) MAPTKDM4EGAAAPAF1RECQL
SCHEMBL9682726 0.75 RAB9A (0.39) MAPTKDM4EGAAHIF1ASMN1; SMN2
SCHEMBL9681773 0.73 MAPT (0.38) MAPTKDM4EALDH1A1GAAHIF1A
SCHEMBL10919184 0.73 ALDH1A1 (0.50) MAPTKDM4EALDH1A1GAABTK
SCHEMBL9680853 0.73 MAPT (0.38) MAPTKDM4EALDH1A1GAAAPAF1
SCHEMBL9846283 0.72 MAPT (0.35) MAPTKDM4EALDH1A1GAAHIF1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0481802-A1 Hydroxylated inhibitors of HIV reverse transcriptase MERCK & CO. INC. (US) 1992-04-22 EP claimed
EP-0481802-A1 Hydroxylated inhibitors of HIV reverse transcriptase MERCK & CO. INC. (US) 1992-04-22 EP disclosed